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PROSTAGLANDIN AND DNA SYNTHESIS IN HUMAN SKIN: POSSIBLE 
RELATIONSHIP TO ULTRAVIOLET LIGHT EFFECTS 
WILLIAM H. EAGLSTEIN , M.D., AND GERALD D. WEINSTEIN, M.D. 
Department of Dermatology, University of Miam i School of Medicine , Miami, Florida 
The effect of prostaglandin E 2 (PGE 2 ) on DNA synthesis in human skin was evaluated. 
PGE 2 (1 J.Lg) was injected intradermally into normal buttock skin of 15 volunteers followed by 
tritiated thymidin_e for autoradiographic quantitation of DNA synthesizing cells. Controls of 
normal saline, histamine (50 J.Lg), and lower doses of PGE 2 were also injected into 8 of the 
volunteers. 
Forty-eight hours after inject ion of 1 J.Lg and 0.1 J.Lg PGE 2 t here was a 264% and 62% 
increase , respectively, in the number of DNA synthesizing epidermal cells/high-power field 
as compared to saline controls. These differences were statistically significant (p < 0.01). 
Histamine (50 J.Lg) produced a statistically significant 36% higher labeling index compared to 
its saline controls (p < 0.05). 
Many types of skin injury, including ultraviolet light (UVL) irradiation, produce an 
increase in the number of DNA synthesizing cells about 48 hr after the stimulus. Our findings 
suggest that PGE, a putative mediator of UVL-induced inflammation, may be one of the 
chemical mediators for the UVL-induced increase in DNA synthesizing cells. Histamine may 
also contribute to the increase in DNA synthesizing cells following UVL-induced inflamma-
tion. 
The prostaglandins are fatty acids which are 
found in many t issues and have a wide variety of 
physiologic actions. Prostaglandins of the E series 
(PGE) cause long-lasting redness when injected 
into skin [1 ]. They are synthesized by human 
skin f2l and have been implicated as mediators of 
ultraviolet light (UVL)-induced inflammation. 
Prostaglandin-like chemicals have been identified 
in dermal perfusates from UVL- irradiated skin [3] 
and PGE has been identified in homogenates of 
UVL-irradiated skin [4 ). Drugs such as indometha-
cin and aspirin, which inhibit the PG synthetase 
system [5 ], will delay and decrease UVL-induced 
inflammation [6]. 
UVL irradiation of normal skin causes an initial 
decrease in the number of epidermal DNA synthe-
sizing (S-phase) cells followed by a 3- to 6-fold 
increase in the number of [3H )thymidine-labeled 
(S-phase) cells at 48 hr after irradiation compared 
to unirradiated skin [7 ]. 
The relationship between UVL-induced inflam-
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mation and UVL-induced changes in DNA synthe-
sis is not understood. If PGE mediates UVL-
induced inflammation, does it also mediate UVL-
induced changes in DNA synthesis? To study this 
question , PGE 2 was injected into normal human 
skin and its effects on DNA synthesis were evalu-
ated by autoradiography and the similarity of 
these effects to those found following UVL irradia-
tion were compared. 
MATERIALS AND METHODS 
PGEz, following confirmation of purity by thin-layer 
chromatography, was diluted in saline for intradermal 
injections of 0.05 ml in amounts of 1 f..Lg , 0.1 f..Lg , 0.01 f..Lg, 
and 0.0001 f..Lg . Intradermal injections of 0.05 ml of saline 
and histamine (50 f..Lg/0.05 ml saline ) were used as 
controls. Fifteen men and women between 45 and 92 
years of age, after signing informed consent forms, 
participated in the study. The injections were performed 
with t uberculin syringes and 26-gauge needles on normal-
appearing buttock skin. Each inject ion produced a dis-
t inct wheal indicating delivery high in the dermis . The 
injection test sites were separated from one another by at 
least 2.5 em. At the appropriate time after administra-
tion of the test agent, [3H]thymidine (sp act 6.0 Ci[mM, 5 
J.LCi/0.1 ml of saline) was injected into each test site. 
Four-millimeter punch biopsy specimens were obtained 
from the test sites 30 to 45 min following the injection of 
the [3H]thymidine. The specimens were fixed in Bouin 's 
solution and prepared for histologic and autoradiographic 
analysis as previously described [8 ]. 
Autoradiographs were examined for heavily labeled 
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cells (more than 10 grains) in the interfollicular epider-
mis. Between 40 and 50 high-power fields (HPF) (ocular 
lO x , objective 40 x ) of each specimen were examined . 
Each HPF was 0.25 mm in surface length and contained 
approximately 50 basal cells along the interfollicular 
epidermis. The results are expressed as the number of 
heavily labeled cells per HPF (labeling index, L. 1. ) 
Three subjects each received 5 injections of 1 ,.,.g PGE 2 
and 5 injections of saline at different sites. At 0.5, 1.5, 3, 
24, and 48 hr . after the PGE 2 and saline injections. 
[ 3H ]thymidine was injected into these test sites followed 
by biopsies. Two subjects were studied only during the 
first three time periods. Ten different subjects were 
injected with saline and 1 ,.,.g PGE 2 , followed by [3H ]-
thymidine and biopsy 48 hr later. Eight of these subjects 
were given additional injections of PGE 2 in lower concen-
trations (0.1, 0.01 , or 0.0001 ,.,.g/0.05 ml ) and an injection 
of histamine solution (50 ,.,.g/0.05 ml) for testing at the 
48-hr time period . 
RESULTS 
Clinically, all injections of PGE 2 produced red-
ness within 2 to 6 min. The area of redness 
following 1 f..l.g of PGE 2 was oval , reaching a 
maximum diameter of 2.5 em within 15 min and 
persisting approximately 5 hr . The lower doses of 
PGE 2 produced a smaller area of redness which 
resolved sooner than the 1-f..l.g dose. Red streaks or 
" tails" extended from the oval PGE 2-induced 
areas of redness. The histamine inject ions pro-
duced immediate redness and marked whealing . 
The histamine-induced redness was less intense 
than the PGE 2-induced redness, extended over a 
larger area (5 em diameter), and resolved within 2 
hr. The saline injections did not produce redness. 
Histologically, there was no apparent difference 
in either the thickness of the epidermis or the 
configuration of the rete ridges among the speci-
mens injected with PGE 2 , histamine, and saline. 
The thymidine labeling indices showed no signif-
icant differences between PGE 2-injected and sa-
line-injected sites over the first 24 hr. The labeling 
indices produced by the saline control injection 
sites were the same over the first 3 hr , but 
increased slightly at 24 and 48 hr after injection 
(Tab. 1) . 
Of major interest was the observation that at 48 
hr after injection there was a 264% increase in the 
number of labeled cells per HPF in the 1 f..l.g PGE2 
TABLE I. Mean labeling indices* in human skin at various 
hours following intradermal injection of 1 ,.,.g PGE 2 and 
saline control 
Hours after injection 
0.5 1.5 3 24 48 
Number of subjects 5 5 5 3 13 
Mean L.I. : saline 1.7 1.8 1.7 2.5 3.1 
Mean L.I.: PGE 2 1 ,.,.g 1.4 2.1 1.7 3.2 8.2 
* Labeling index (L.I.) = number of tritiated thymi-
dine labeled epidermal cells/high-power field (50 basal 
cells) . 
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TABLE II . The effects of intradermal PGE2 , histamine , 
and saline on labeling indices at 48 hr after injection 
Number of labeled cells per high-power field 
PGE 2 Hista-
Saline mine 
1 ~g 0.1 ~g 0.01 ~g 0.0001 ~g 50~g 
Pt.# 1 4.8 12.1 
2 2.7 20.0 
3 5.1 12.3 
4 2.9 6.4 
5 2.2 8.8 
6 2.1 5.2 5.5 3.5 
7 3.1 4.1 3.8 7.7 1.8 3.2 
8 4.7 10.7 5.5 4.7 6.8 
9 2.9 4.8 4.1 3.4 3.0 
10 3.4 7.7 5.5 4.5 2.6 
11 2.5 8.5 5.6 1.8 4.9 
12 1.8 0.6 6.5 4.0 2.6 
13 1.6 5.2 3.0 1.9 3.6 
Mean 3.1 8.2 4.7 4.7 3.2 3.8 
Standard 
error 0.32 1.3 0.8 1.1 0.7 0.4 
sites as compared to their saline controls. This 
difference is statistically significant, p < 0.01 
(matched-pair comparison). The lower dose of 0.01 
f..l.g PGE 2 caused a 62% increase in the labeling 
index at 48 hr ( p < 0.01, matched-pair compari-
son). Histamine (50 f.J.g ) produced a 36% higher 
labeling index compared to its saline controls (p < 
0.05, matched-pair comparison) (Tab. II). 
DISCUSSION 
We have demonstrated that an erythema-pro-
ducing intradermal injection of PGE2 into normal 
skin is associated with an increase in epidermal 
DNA synthesizing cells at 48 hr following injection. 
This is the same time at which an increase in 
S-phase cells occurs in UVL-irradiated skin. The 
prostaglandin doses used in this study are well 
within ranges reported in UVL-damaged skin [4 ]. 
The lowest doses which increased the number of 
S-phase c~lls (0.1 and 0.01 ,ug) are below those 
reported in skin [9, 10 ]. 
An increase in human epidermal S-phase cells at 
24 to 48 hr can be demonstrated following several 
different stimuli: UVL irradiation [7 ], Scotch-tape 
stripping f11 ], incisional wounding [12 ], and 
friction [13 ]. A similar increase in the number of 
S-phase cells also has been noted in certain animal 
models with specific timed increases following 
stimuli such as skin friction [14], wounding [15 ], 
isoproteranol injections into mice for salivary 
gland cell proliferation [16 ], and mouse hepatocel-
lular injury. These observations suggest that cell 
proliferation in response to certain stimuli requires 
a finite time period to develop . 
One can only speculate at this time on how PGE 2 
administration affects the epidermal cell cycle. 
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Since the labeling index did not decrease but 
remained relatively normal from 1 to 24 hr follow-
ing PGE 2 injection (Tab. I), there does not appear 
to be a block in the movement of cells from G 1 into 
the S-phase. However, at 48 hr following PGE 2 
injection, a "burst" of cells appears in the S phase 
suggesting either an abrupt shortening of the G 1 
period or stimulation of G 1 cells into the S phase as 
a synchronous group. Theoretically it could also 
reflect a stimulation of G 0 cells into the S phase at 
48 hr , but as yet there is no evidence supporting the 
existence of Go cells in human epidermis. 
The failure to find an initial . decrease in the 
number of epidermal DNA synthesizing cells fol-
lowing PGE 2 injection supports the suggestion that 
the decreased number of S-phase epidermal cells 
seen within the first few hours after UVL irradia-
tion is due to a direct damaging effect of UVL on 
epidermal DNA [17 ]. 
At the molecular level, the prostaglandins and 
cyclic nucleotides appear to modulate various 
cellular functions. In general, prostaglandins of the 
E series stimulate an increase in the levels of cyclic 
AMP (cAMP); however, the relationship between 
cAMP and DNA synthesis is variable. Increased 
DNA synthesis is associated with increased cAMP 
levels in rat salivary gland following isoproteranol 
injection [18 ], whereas increased DNA synthesis 
is associated with decreased cAMP levels in fibro-
blastic cell cultures stimulated with GMP [19]. 
Cultured fibroblasts are associated with varying 
cAMP levels throughout the cell cycle but cGMP 
increases are found in the early G 1 phase [20 ). A 
recent review of the literature [21] with special 
emphasis on model systems employing thymocytes 
and regenerating liver cells concludes that in-
creased DNA synthesis follows an increase in 
cAMP levels. 
When normal and psoriatic epidermal cells were 
studied in vitro, the addition of dibutyryl cAMP in 
high concentrations inhibited mitoses [22,23 ]. 
However, in the rapidly proliferating psoriatic 
epidermis, both . increased [24,25] and de-
creased [26] levels of cAMP have been reported, 
leading to conflicting interpretations of the rela-
tionship between cAMP and mitotic behavior. 
Prostaglandins of the E series are reported in in 
vitro e_piqermal cell systems to increase cAMP 
levels [27,28 ]. Since cAMP concentrations were 
not measured in the present in vivo studies, we are 
unable to clarify the relationship between our data 
and the cAMP effects of DNA synthesizing cells. 
As PGE 2 plays a role in the inflammatory 
response to UVL irradiation, our present findings 
suggest that PGE 2 may be one of the mediators of 
the increased number of S-phase cells seen follow-
ing UVL irradiation. Histamine has also been 
reported in dermal perfusates of UVL-irradiated 
skin [29 ]. Since an increased number of S-phase 
cells was found 48 hr following histamine injection, 
it is possible that histamine also contributes to the 
increased number of DNA synthesizing c~lls fol-
lowing UVL irradiation. However, the dramatic 
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whealing from our histamine injection of 50 J.Lg is 
not seen in the skin following UVL irradiation. The 
demonstration that defined chemical molecules are 
capable of stimulating proliferative cell activity in 
the skin may be significant for future biochemical 
and cytokinetic studies. 
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